GleamWall
中文EN

FEMY FEMASYS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1339005 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.2%
TTM net income YoY38.7%
TTM EPS YoY175.8%
Revenue 3-yr CAGR21.8%
Net income 3-yr CAGR—

Margins

Gross margin59.9%
Operating margin-929.9%
Net margin-614.7%
FCF margin-877.5%
EBITDA margin-913.3%

Returns

ROE-76.9%
ROA-47.3%
ROIC (approx.)-935.4%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets23.0%
Debt / equity0.00x
Current ratio8.67x
Interest coverage-18.91x

Cash quality & payout

Operating cash flow / net income1.41x
Accruals ratio19.2%
Payout ratio—
Capex / revenue12.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.29M$1.63M
Cost of revenue$872,400$544,903
Gross profit$1.42M$1.08M
R&D expense$7.58M$8.22M
SG&A expense$6.65M$6.33M
Operating income-$17.59M-$17.79M
Interest expense$1.89M$1.60M
Pretax income-$18.63M-$18.81M
Income tax$1,297$9,602
Net income-$18.63M-$18.82M
EBITDA-$17.25M-$17.49M
EPS (basic)-0.47-0.85
EPS (diluted)-0.47-0.85
Weighted avg. shares (diluted)39.55M22.27M
Balance sheet
Cash & equivalents$9.27M$3.45M
Receivables$616,600$488,373
Inventory$5.74M$3.05M
Current assets$16.46M$8.02M
PP&E, net$1.90M$1.60M
Intangibles$134,914$65,918
Total assets$20.72M$12.45M
Current liabilities$3.64M$8.58M
Total liabilities$14.85M$10.14M
Shareholders' equity$5.87M$2.30M
Shares outstanding2.98M23.36M
Cash flow statement
Operating cash flow-$18.69M-$19.44M
Capital expenditure$525,007$761,706
Free cash flow-$19.22M-$20.21M
Investing cash flow-$630,098-$847,764
Financing cash flow$25.14M$2.03M
Depreciation & amortization$342,034$297,318
Stock-based compensation$790,145$444,147
Share buybacks—$60,753

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.